Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 33 | 2025 | 2021 | 4.320 |
Why?
|
Heart Valve Prosthesis Implantation | 23 | 2024 | 1564 | 3.540 |
Why?
|
Aortic Valve | 24 | 2025 | 1968 | 2.250 |
Why?
|
Myocardial Infarction | 26 | 2023 | 11513 | 1.790 |
Why?
|
Shock, Cardiogenic | 12 | 2023 | 709 | 1.770 |
Why?
|
Mitral Valve Insufficiency | 10 | 2024 | 1414 | 1.740 |
Why?
|
Tricuspid Valve | 4 | 2024 | 419 | 1.610 |
Why?
|
Patient Readmission | 20 | 2023 | 3283 | 1.520 |
Why?
|
Hospital Mortality | 49 | 2024 | 5345 | 1.350 |
Why?
|
Plasma Kallikrein | 3 | 2016 | 21 | 1.300 |
Why?
|
Ischemic Attack, Transient | 3 | 2023 | 874 | 1.220 |
Why?
|
Myocardial Revascularization | 6 | 2020 | 795 | 0.980 |
Why?
|
Cardiovascular Agents | 5 | 2020 | 849 | 0.970 |
Why?
|
Hospital Costs | 14 | 2021 | 956 | 0.910 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2024 | 361 | 0.830 |
Why?
|
Inpatients | 18 | 2020 | 2563 | 0.830 |
Why?
|
Postoperative Complications | 21 | 2024 | 15824 | 0.820 |
Why?
|
Ischemia | 3 | 2021 | 1905 | 0.810 |
Why?
|
Mitral Valve | 10 | 2024 | 1475 | 0.800 |
Why?
|
Myocardial Ischemia | 7 | 2023 | 2131 | 0.780 |
Why?
|
Endovascular Procedures | 7 | 2020 | 2215 | 0.770 |
Why?
|
Databases, Factual | 27 | 2025 | 8068 | 0.770 |
Why?
|
Foramen Ovale, Patent | 2 | 2021 | 210 | 0.740 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 43 | 0.740 |
Why?
|
Treatment Outcome | 72 | 2025 | 65295 | 0.730 |
Why?
|
Vascular Grafting | 2 | 2020 | 163 | 0.720 |
Why?
|
Stroke | 14 | 2025 | 9746 | 0.700 |
Why?
|
Risk Factors | 74 | 2025 | 74886 | 0.700 |
Why?
|
Acute Coronary Syndrome | 4 | 2021 | 2193 | 0.690 |
Why?
|
Intracranial Embolism | 1 | 2021 | 188 | 0.670 |
Why?
|
Registries | 13 | 2025 | 8351 | 0.670 |
Why?
|
Plaque, Atherosclerotic | 2 | 2021 | 1549 | 0.660 |
Why?
|
Coronary Artery Bypass | 9 | 2021 | 2189 | 0.650 |
Why?
|
United States | 76 | 2025 | 72971 | 0.640 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1304 | 0.640 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 280 | 0.630 |
Why?
|
Peripartum Period | 2 | 2017 | 137 | 0.630 |
Why?
|
Time Factors | 46 | 2025 | 40154 | 0.620 |
Why?
|
Aged, 80 and over | 54 | 2025 | 59548 | 0.610 |
Why?
|
Heart Failure | 9 | 2022 | 11877 | 0.600 |
Why?
|
Antithrombins | 1 | 2021 | 294 | 0.600 |
Why?
|
Cardiology | 5 | 2023 | 1701 | 0.600 |
Why?
|
Risk Assessment | 33 | 2025 | 24299 | 0.590 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1029 | 0.590 |
Why?
|
Aminopyridines | 2 | 2012 | 578 | 0.580 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2018 | 277 | 0.570 |
Why?
|
Catheterization, Peripheral | 2 | 2022 | 346 | 0.570 |
Why?
|
Propensity Score | 10 | 2021 | 1971 | 0.560 |
Why?
|
Heart Valve Prosthesis | 7 | 2020 | 1464 | 0.550 |
Why?
|
Atrial Appendage | 4 | 2021 | 285 | 0.550 |
Why?
|
Incidence | 31 | 2024 | 21526 | 0.540 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2020 | 2144 | 0.520 |
Why?
|
Humans | 159 | 2025 | 767040 | 0.520 |
Why?
|
Drug-Eluting Stents | 3 | 2018 | 681 | 0.520 |
Why?
|
Malnutrition | 1 | 2022 | 632 | 0.520 |
Why?
|
Radial Artery | 2 | 2022 | 187 | 0.520 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2014 | 222 | 0.510 |
Why?
|
Aged | 85 | 2025 | 171319 | 0.500 |
Why?
|
Length of Stay | 21 | 2021 | 6489 | 0.490 |
Why?
|
Hospitals | 5 | 2021 | 3883 | 0.490 |
Why?
|
Specialty Boards | 1 | 2017 | 235 | 0.490 |
Why?
|
Cardiovascular Diseases | 9 | 2021 | 15645 | 0.490 |
Why?
|
Puerperal Disorders | 2 | 2017 | 304 | 0.490 |
Why?
|
Kininogen, High-Molecular-Weight | 2 | 2011 | 6 | 0.480 |
Why?
|
Extremities | 2 | 2021 | 870 | 0.470 |
Why?
|
Coronary Angiography | 8 | 2021 | 4525 | 0.470 |
Why?
|
Odds Ratio | 16 | 2021 | 9660 | 0.450 |
Why?
|
Endocarditis | 1 | 2018 | 352 | 0.450 |
Why?
|
Heart Aneurysm | 1 | 2014 | 114 | 0.440 |
Why?
|
Certification | 1 | 2017 | 420 | 0.440 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1946 | 0.430 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2017 | 519 | 0.430 |
Why?
|
Heart Arrest | 4 | 2017 | 1516 | 0.430 |
Why?
|
Femoral Artery | 2 | 2022 | 827 | 0.430 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 497 | 0.420 |
Why?
|
Saphenous Vein | 1 | 2016 | 519 | 0.410 |
Why?
|
Retrospective Studies | 56 | 2024 | 81659 | 0.410 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 538 | 0.400 |
Why?
|
Male | 101 | 2025 | 364203 | 0.400 |
Why?
|
Survival Rate | 18 | 2019 | 12823 | 0.390 |
Why?
|
Septal Occluder Device | 3 | 2021 | 126 | 0.390 |
Why?
|
Hospitalization | 9 | 2021 | 10815 | 0.390 |
Why?
|
Pacemaker, Artificial | 4 | 2024 | 828 | 0.380 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2011 | 24 | 0.380 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1944 | 0.380 |
Why?
|
Female | 100 | 2025 | 396660 | 0.380 |
Why?
|
Patient Care Team | 2 | 2020 | 2516 | 0.370 |
Why?
|
Patient Discharge | 9 | 2021 | 3467 | 0.360 |
Why?
|
Magnesium | 1 | 2014 | 815 | 0.360 |
Why?
|
Atrial Fibrillation | 8 | 2024 | 5180 | 0.360 |
Why?
|
Cardiac Surgical Procedures | 2 | 2023 | 3683 | 0.350 |
Why?
|
Skilled Nursing Facilities | 4 | 2021 | 405 | 0.350 |
Why?
|
Forecasting | 2 | 2018 | 2936 | 0.350 |
Why?
|
Electrocardiography | 9 | 2018 | 6409 | 0.340 |
Why?
|
Angina, Unstable | 1 | 2013 | 893 | 0.330 |
Why?
|
Cardiotonic Agents | 2 | 2015 | 540 | 0.320 |
Why?
|
Coronary Artery Disease | 6 | 2020 | 6573 | 0.320 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2764 | 0.320 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2954 | 0.300 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 843 | 0.300 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3431 | 0.300 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2019 | 93 | 0.290 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.290 |
Why?
|
Lipopolysaccharides | 2 | 2012 | 2217 | 0.280 |
Why?
|
Contrast Media | 2 | 2020 | 5329 | 0.280 |
Why?
|
Logistic Models | 11 | 2021 | 13284 | 0.280 |
Why?
|
Middle Aged | 55 | 2021 | 223233 | 0.270 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3700 | 0.260 |
Why?
|
Blood Coagulation | 1 | 2012 | 1163 | 0.260 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 2 | 2020 | 131 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2021 | 2299 | 0.250 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 575 | 0.240 |
Why?
|
Erythrocyte Transfusion | 2 | 2020 | 575 | 0.230 |
Why?
|
Comorbidity | 12 | 2021 | 10582 | 0.230 |
Why?
|
Cause of Death | 6 | 2021 | 3717 | 0.230 |
Why?
|
Medicare | 4 | 2025 | 6813 | 0.230 |
Why?
|
Morbidity | 6 | 2019 | 1754 | 0.230 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3726 | 0.230 |
Why?
|
Influenza, Human | 3 | 2021 | 1543 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2020 | 1337 | 0.220 |
Why?
|
Cardiomyopathies | 4 | 2018 | 2057 | 0.220 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 881 | 0.220 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1889 | 0.210 |
Why?
|
Disease Management | 3 | 2021 | 2531 | 0.210 |
Why?
|
International Classification of Diseases | 2 | 2021 | 935 | 0.200 |
Why?
|
Secondary Prevention | 2 | 2021 | 1472 | 0.200 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2018 | 773 | 0.200 |
Why?
|
American Heart Association | 3 | 2023 | 1049 | 0.190 |
Why?
|
Follow-Up Studies | 16 | 2021 | 39317 | 0.190 |
Why?
|
Endothelial Cells | 2 | 2011 | 3582 | 0.190 |
Why?
|
Research Design | 1 | 2017 | 6210 | 0.190 |
Why?
|
Kidney Failure, Chronic | 4 | 2018 | 2495 | 0.190 |
Why?
|
Cost of Illness | 4 | 2020 | 1951 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2024 | 421 | 0.180 |
Why?
|
Atrial Septum | 1 | 2021 | 61 | 0.180 |
Why?
|
Multivariate Analysis | 7 | 2021 | 12069 | 0.170 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3934 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 2 | 2024 | 2257 | 0.170 |
Why?
|
Epoprostenol | 2 | 2011 | 246 | 0.170 |
Why?
|
Age Factors | 8 | 2021 | 18401 | 0.170 |
Why?
|
Renal Dialysis | 3 | 2018 | 1790 | 0.170 |
Why?
|
Coronary Vessels | 2 | 2021 | 3114 | 0.170 |
Why?
|
Sepsis | 2 | 2021 | 2605 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1243 | 0.160 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 42 | 0.160 |
Why?
|
Hypertension | 5 | 2021 | 8615 | 0.160 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2017 | 996 | 0.160 |
Why?
|
Nutrition Assessment | 1 | 2022 | 740 | 0.160 |
Why?
|
Coronary Disease | 2 | 2023 | 5914 | 0.160 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 216 | 0.150 |
Why?
|
Sex Factors | 6 | 2021 | 10622 | 0.150 |
Why?
|
Stents | 2 | 2021 | 3193 | 0.150 |
Why?
|
Mitral Valve Prolapse | 1 | 2020 | 213 | 0.150 |
Why?
|
Renal Artery | 1 | 2020 | 355 | 0.150 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 285 | 0.150 |
Why?
|
Death | 1 | 2022 | 685 | 0.150 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 193 | 0.140 |
Why?
|
Tachycardia, Ventricular | 2 | 2018 | 1313 | 0.140 |
Why?
|
Denmark | 1 | 2019 | 776 | 0.140 |
Why?
|
Prevalence | 9 | 2021 | 15851 | 0.140 |
Why?
|
Patient Admission | 2 | 2015 | 1364 | 0.140 |
Why?
|
Endarterectomy | 1 | 2017 | 196 | 0.140 |
Why?
|
Hemorrhage | 5 | 2023 | 3464 | 0.140 |
Why?
|
Echocardiography | 4 | 2019 | 5042 | 0.140 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1883 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 10393 | 0.140 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2018 | 91 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2021 | 1156 | 0.140 |
Why?
|
New Mexico | 1 | 2016 | 80 | 0.130 |
Why?
|
Antigens, CD34 | 1 | 2018 | 655 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 646 | 0.130 |
Why?
|
Rhode Island | 1 | 2016 | 352 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15925 | 0.120 |
Why?
|
Heart-Assist Devices | 2 | 2017 | 1287 | 0.120 |
Why?
|
Bioprosthesis | 1 | 2019 | 593 | 0.120 |
Why?
|
Punctures | 1 | 2016 | 371 | 0.120 |
Why?
|
Patient Selection | 2 | 2024 | 4256 | 0.120 |
Why?
|
Prognosis | 8 | 2019 | 29963 | 0.120 |
Why?
|
Rural Population | 2 | 2022 | 2321 | 0.120 |
Why?
|
Health Status Disparities | 4 | 2020 | 1882 | 0.120 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4268 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2018 | 956 | 0.110 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 48 | 0.110 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1208 | 0.110 |
Why?
|
Nutritional Status | 1 | 2022 | 1628 | 0.110 |
Why?
|
Coronary Circulation | 1 | 2020 | 1603 | 0.110 |
Why?
|
Exercise Test | 1 | 2021 | 2188 | 0.110 |
Why?
|
Medicaid | 2 | 2018 | 2836 | 0.110 |
Why?
|
Aortic Diseases | 1 | 2019 | 741 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 166 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6310 | 0.100 |
Why?
|
Acetanilides | 1 | 2014 | 168 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2018 | 2787 | 0.100 |
Why?
|
Patient Transfer | 2 | 2018 | 788 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2020 | 858 | 0.100 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1096 | 0.100 |
Why?
|
Age Distribution | 4 | 2020 | 2870 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2023 | 284 | 0.100 |
Why?
|
Sex Distribution | 4 | 2018 | 2276 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1308 | 0.100 |
Why?
|
Quality Improvement | 2 | 2019 | 3854 | 0.100 |
Why?
|
Nitric Oxide | 2 | 2011 | 2140 | 0.100 |
Why?
|
Drug Costs | 1 | 2020 | 1196 | 0.100 |
Why?
|
Kidney | 2 | 2017 | 7063 | 0.100 |
Why?
|
Stroke Volume | 2 | 2023 | 5618 | 0.100 |
Why?
|
Prekallikrein | 1 | 2011 | 11 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 445 | 0.100 |
Why?
|
Blood Coagulation Disorders | 1 | 2015 | 350 | 0.090 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2012 | 187 | 0.090 |
Why?
|
Syncope | 1 | 2014 | 431 | 0.090 |
Why?
|
Emergencies | 1 | 2018 | 1223 | 0.090 |
Why?
|
Maternal Mortality | 1 | 2014 | 310 | 0.090 |
Why?
|
Calcinosis | 1 | 2020 | 1481 | 0.090 |
Why?
|
Signal Transduction | 2 | 2011 | 23621 | 0.090 |
Why?
|
Hemodynamics | 2 | 2020 | 4186 | 0.090 |
Why?
|
Health Resources | 1 | 2017 | 948 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2017 | 803 | 0.090 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1368 | 0.090 |
Why?
|
Bradykinin | 1 | 2011 | 205 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2015 | 602 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1499 | 0.090 |
Why?
|
Smoking | 3 | 2021 | 9081 | 0.090 |
Why?
|
Verapamil | 1 | 2011 | 242 | 0.090 |
Why?
|
Cohort Studies | 4 | 2022 | 41718 | 0.090 |
Why?
|
Creatinine | 1 | 2016 | 1916 | 0.090 |
Why?
|
Phenylephrine | 1 | 2011 | 292 | 0.090 |
Why?
|
Adult | 22 | 2021 | 223317 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1129 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2817 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1248 | 0.090 |
Why?
|
Drug Combinations | 1 | 2016 | 2086 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5537 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1506 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2006 | 0.080 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 701 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1596 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1804 | 0.080 |
Why?
|
Heart Conduction System | 1 | 2015 | 1008 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10748 | 0.080 |
Why?
|
Fee-for-Service Plans | 2 | 2024 | 713 | 0.080 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15424 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1965 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7236 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1188 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 1142 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2016 | 2120 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8048 | 0.080 |
Why?
|
Recurrence | 2 | 2018 | 8504 | 0.080 |
Why?
|
Home Care Services | 1 | 2015 | 659 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2227 | 0.080 |
Why?
|
Population Surveillance | 1 | 2018 | 2594 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 2 | 2021 | 488 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1567 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4143 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2020 | 1712 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1750 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4854 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2011 | 988 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 3 | 2018 | 1741 | 0.070 |
Why?
|
Nursing Homes | 1 | 2014 | 1084 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2015 | 1481 | 0.070 |
Why?
|
Obesity | 3 | 2021 | 13085 | 0.070 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5886 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2099 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2011 | 1208 | 0.060 |
Why?
|
Gadolinium | 1 | 2011 | 964 | 0.060 |
Why?
|
Rabbits | 1 | 2012 | 4751 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7871 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3001 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3232 | 0.060 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3414 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2598 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2011 | 18989 | 0.060 |
Why?
|
Rats | 2 | 2012 | 23713 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3535 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2513 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3641 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4306 | 0.060 |
Why?
|
Heart Transplantation | 2 | 2015 | 3305 | 0.060 |
Why?
|
Pregnancy | 2 | 2017 | 30238 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18330 | 0.060 |
Why?
|
Thrombosis | 2 | 2021 | 2954 | 0.050 |
Why?
|
Plasmapheresis | 2 | 2015 | 205 | 0.050 |
Why?
|
Piperazines | 1 | 2014 | 2548 | 0.050 |
Why?
|
Kinetics | 1 | 2011 | 6287 | 0.050 |
Why?
|
Young Adult | 7 | 2022 | 59980 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2972 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3345 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2021 | 3234 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4424 | 0.050 |
Why?
|
Endpoint Determination | 1 | 2025 | 592 | 0.050 |
Why?
|
Health Status | 3 | 2020 | 4091 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 279 | 0.050 |
Why?
|
Recovery of Function | 2 | 2024 | 2978 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 89046 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 1 | 2012 | 8108 | 0.050 |
Why?
|
Chronic Disease | 3 | 2023 | 9362 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3928 | 0.050 |
Why?
|
Superinfection | 1 | 2021 | 61 | 0.040 |
Why?
|
Software | 1 | 2015 | 4472 | 0.040 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2025 | 463 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 200 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4855 | 0.040 |
Why?
|
Learning Curve | 1 | 2021 | 232 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4713 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 305 | 0.040 |
Why?
|
Mortality | 2 | 2022 | 2909 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5875 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 316 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4881 | 0.040 |
Why?
|
Splanchnic Circulation | 1 | 2019 | 122 | 0.040 |
Why?
|
Calcium | 1 | 2011 | 5792 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5186 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 2017 | 338 | 0.030 |
Why?
|
Normal Distribution | 1 | 2017 | 267 | 0.030 |
Why?
|
Animals | 3 | 2014 | 168965 | 0.030 |
Why?
|
Equipment Design | 1 | 2024 | 3489 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2017 | 486 | 0.030 |
Why?
|
Databases as Topic | 1 | 2018 | 472 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 771 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1319 | 0.030 |
Why?
|
Dobutamine | 1 | 2015 | 114 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5947 | 0.030 |
Why?
|
Endarterectomy, Carotid | 1 | 2020 | 556 | 0.030 |
Why?
|
Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22350 | 0.030 |
Why?
|
Systole | 1 | 2017 | 935 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2021 | 939 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 935 | 0.030 |
Why?
|
Shock, Septic | 1 | 2021 | 772 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 2015 | 171 | 0.030 |
Why?
|
India | 1 | 2021 | 2334 | 0.030 |
Why?
|
Walking | 1 | 2021 | 1201 | 0.030 |
Why?
|
Radiation Protection | 1 | 2017 | 428 | 0.030 |
Why?
|
New York | 1 | 2016 | 879 | 0.030 |
Why?
|
Sampling Studies | 1 | 2015 | 614 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2021 | 872 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2015 | 386 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2118 | 0.030 |
Why?
|
Hospital Charges | 1 | 2015 | 345 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2018 | 846 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1512 | 0.030 |
Why?
|
Nitrates | 1 | 2014 | 259 | 0.030 |
Why?
|
Utilization Review | 1 | 2014 | 381 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1666 | 0.030 |
Why?
|
Cost Savings | 1 | 2017 | 904 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4026 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1240 | 0.020 |
Why?
|
Uncertainty | 1 | 2017 | 765 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 418 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1250 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54886 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10869 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 810 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 688 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20741 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 965 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 667 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2018 | 1161 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3207 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1836 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2227 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2519 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2920 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3618 | 0.020 |
Why?
|
Disabled Persons | 1 | 2018 | 1209 | 0.020 |
Why?
|
Body Mass Index | 2 | 2016 | 13048 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1636 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1101 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9360 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1092 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4056 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9606 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2025 | 20169 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3434 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.020 |
Why?
|
Warfarin | 1 | 2015 | 1493 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 3139 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7848 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6513 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3837 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4210 | 0.010 |
Why?
|
Critical Care | 1 | 2014 | 2714 | 0.010 |
Why?
|
Blood Pressure | 1 | 2017 | 8531 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13485 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36485 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26325 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42606 | 0.010 |
Why?
|
Child | 1 | 2018 | 80771 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36582 | 0.000 |
Why?
|